Advanced search
Publication Cover
Leukemia & Lymphoma Volume 64, 2023 - Issue 5
Submit an article Journal homepage
2,657
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Impact of KRAS and NRAS mutations on outcomes in acute myeloid leukemia

Moaath K. Mustafa Alia Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD, USA;b Leukemia Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USAORCID Iconhttps://orcid.org/0000-0003-3289-2333View further author information
ORCID Icon,
Matthew T. Williamsc Department of Medicine, School of Medicine, University of Maryland, Baltimore, MD, USAView further author information
,
Elizabeth M. Corleyd Department of Medicine, Weil-Cornell Medical Center, New York, NY, USAView further author information
,
Fahad AlKaabbac Department of Medicine, School of Medicine, University of Maryland, Baltimore, MD, USAView further author information
&
Sandrine Niyongerea Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD, USACorrespondence[email protected]
View further author information
Pages 962-971 | Received 29 Sep 2022, Accepted 04 Mar 2023, Published online: 12 Apr 2023

References

  • Döhner H, Wei AH, Appelbaum FR, et al. Diagnosis and management of AML in adults: 2022 ELN recommendations from an international expert panel. Blood. 2022;140(12):1345–1377.
  • Bowen DT, Frew ME, Hills R, et al. RAS mutation in acute myeloid leukemia is associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 years. Blood. 2005;106(6):2113–2119.
  • Zhou JD, Yao DM, Li XX, et al. KRAS overexpression independent of RAS mutations confers an adverse prognosis in cytogenetically normal acute myeloid leukemia. Oncotarget. 2017;8(39):66087–66097.
  • Ball BJ, Hsu M, Devlin SM, et al. The prognosis and durable clearance of RAS mutations in patients with acute myeloid leukemia receiving induction chemotherapy. Am J Hematol. 2021;96(5):E171–E175.
  • Neubauer A, Dodge R, George S, et al. Prognostic importance of mutations in the ras proto-oncogenes in de novo acute myeloid leukemia. Blood. 1994;83(6):1603–1611.
  • Rivera D, Kim K, Kanagal-Shamanna R, et al. Implications of RAS mutational status in subsets of patients with newly diagnosed acute myeloid leukemia across therapy subtypes. Am J Hematol. 2022 Dec; 97(12):1599–1606.
  • Ahmad EI, Gawish HH, Al Azizi NM, et al. The prognostic impact of K-RAS mutations in adult acute myeloid leukemia patients treated with high-dose cytarabine. Onco Targets Ther. 2011;4:115–121.
  • Neubauer A, Maharry K, Mrózek K, et al. Patients with acute myeloid leukemia and RAS mutations benefit most from postremission high-dose cytarabine: a cancer and leukemia group B study. J Clin Oncol. 2008;26(28):4603–4609.
  • Mustafa Ali MK, Corley EM, Alharthy H, et al. Outcomes of Newly Diagnosed Acute Myeloid Leukemia Patients Treated With Hypomethylating Agents With or Without Venetoclax: A Propensity Score-Adjusted Cohort Study. Front Oncol. 2022;12:858202.
  • Corley EM, Mustafa Ali MK, Alharthy H, et al. Impact of IDH1 c.315C > T SNP on Outcomes in Acute Myeloid Leukemia: A Propensity Score-Adjusted Cohort Study. Front Oncol. 2022 Mar 18;12:804961.
  • Corley EM, Mustafa Ali MK, Alharthy H, et al. Impact of FLT3-ITD insertion length on outcomes in acute myeloid leukemia: a propensity score-adjusted cohort study. Biology. 2022;11(6):916.
  • Epic Systems. 2019. [2019-05-26]. Epic: About https://www.epic.com/about.
  • Harris PA, Taylor R, Minor BL, REDCap Consortium, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208.
  • Harder VS, Stuart EA, Anthony JC. Propensity score techniques and the assessment of measured covariate balance to test causal associations in psychological research. Psychol Methods. 2010;15(3):234–249.
  • Austin PC. Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysis. Stat Med. 2016;35(30):5642–5655.
  • Greifer N. WeightIt: weighting for covariate balance in observational studies [cited 2022 Jul 15]. Available from: https://ngreifer.github.io/WeightIt/.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.